Effects of TECAR, Sham TECAR and Conventional Physiotherapy in Patients with Knee Osteoarthritis on physical function , disability and quality of life: A Randomized Control Trial
Overview
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Alisha Paudel
- Enrollment
- 72
- Locations
- 1
- Primary Endpoint
- Disability
Overview
Brief Summary
This study is a randomized controlled trial designed to compare the effects of TECAR therapy, sham TECAR, and conventional physiotherapy in patients with Grade 2–3 knee osteoarthritis. The aim is to determine whether adding TECAR therapy provides additional benefits in terms of pain reduction, improved joint mobility, functional ability, disability, and quality of life.
A total of 72 participants will be randomly assigned into three groups:
- TECAR + Conventional Physiotherapy
- Sham TECAR + Conventional Physiotherapy
- Conventional Physiotherapy only
The intervention will last 4 weeks (12 sessions). Outcome measures include VAS for pain, ROM (goniometer), strength (isokinetic dynamometer), WOMAC, and WHO-QOL. Data will be analyzed using One-way ANOVA.
The study addresses a major research gap because few previous studies used a sham group and the evidence regarding TECAR’s effectiveness in knee OA is still conflicting. By including a placebo group, this trial aims to clearly evaluate if improvements are due to the actual TECAR effect or placebo.
The findings are expected to guide physiotherapists in making evidence-based decisions regarding TECAR therapy in knee OA management.
Study Design
- Study Type
- Interventional
- Allocation
- Coin toss, Lottery, toss of dice, shuffling cards etc
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 40.00 Year(s) to 75.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patients with knee pain aged between 40 to 75 years both male and female.
- •Clinically diagnosed cases with knee OA Grade 2 and 3 according to Kellgren Lawrence classification from X ray.
- •Patients with pain duration of more than 3 months.
- •Participants expressing voluntary participation and providing informed consent.
Exclusion Criteria
- •History of recent knee injury operation and intraarticular injection within the last 6 months to 1 year Patients with any obvious knee deformity and limb length descrepency Known history of neurological infectious inflammatory or systemic diseases affecting lower limbs Patients with known history of cardiac pacemakers malignancies or contraindications for TECAR therapy Patients reported to undergo other physiotherapy treatments during the study period Chronic pharmacological treatment with corticosteroids or NSAIDs for 6 month.
Outcomes
Primary Outcomes
Disability
Time Frame: 4 weeks
Quality of life
Time Frame: 4 weeks
Pain
Time Frame: 4 weeks
Secondary Outcomes
- Range of Motion(Muscle strength)
Investigators
Alisha Paudel
Amity Institute of Health and Allied Science